References |
Top |
REF 1 |
Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7414-9.
|
REF 2 |
Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus. PLoS Pathog. 2010 Dec 23;6(12):e1001238.
|
REF 3 |
Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J Biol Chem. 2006 Aug 4;281(31):21640-51.
|
REF 4 |
c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF- type II receptor. Mol Cell. 2013 Feb 7;49(3):499-510.
|
REF 5 |
A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways. Cell. 2014 Jul 17;158(2):434-448.
|
REF 6 |
Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat Methods. 2006 Dec;3(12):981-3.
|
REF 7 |
Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 1997 Oct 3;278(5335):124-8.
|
REF 8 |
Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Oncogene. 1997 May 8;14(18):2217-28.
|
REF 9 |
B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J Biol Chem. 1996 Dec 13;271(50):32306-14.
|
REF 10 |
Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages. J Leukoc Biol. 1999 Apr;65(4):523-34.
|
REF 11 |
Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling. Exp Cell Res. 1998 Dec 15;245(2):330-42.
|
REF 12 |
CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J Cell Biochem. 1999 Jan 1;72(1):119-34.
|
REF 13 |
Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J Biol Chem. 1995 Oct 27;270(43):25332-5.
|
REF 14 |
Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J Biol Chem. 2005 Apr 8;280(14):13442-9.
|
REF 15 |
Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem. 1996 Jun 14;271(24):14554-9.
|
REF 16 |
p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1996 Feb 9;271(6):3187-94.
|
REF 17 |
The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J Biol Chem. 1995 Aug 11;270(32):19141-50.
|
REF 18 |
cbl-b inhibits epidermal growth factor receptor signaling. Oncogene. 1999 Mar 11;18(10):1855-66.
|
REF 19 |
FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6684-9.
|
REF 20 |
High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. J Immunol. 1999 Dec 1;163(11):6023-34.
|
REF 21 |
Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J Biol Chem. 1998 Feb 13;273(7):3986-93.
|
REF 22 |
A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J. 2002 Feb 1;21(3):303-13.
|
REF 23 |
TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Oncogene. 2004 Jun 10;23(27):4690-706.
|
REF 24 |
Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem Biophys Res Commun. 2000 Nov 11;278(1):167-74.
|
REF 25 |
Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem. 2003 Oct 10;278(41):39735-46.
|
REF 26 |
The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature. 2002 Mar 14;416(6877):187-90.
|
REF 27 |
Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature. 2002 Mar 14;416(6877):183-7.
|
REF 28 |
CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem. 2002 Oct 18;277(42):39666-72.
|
REF 29 |
SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins. Cell Signal. 2000 Dec;12(11-12):769-79.
|
REF 30 |
Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix. Oncogene. 2006 May 18;25(21):3071-8.
|
REF 31 |
Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol. 2004 Oct;24(20):8981-93.
|
REF 32 |
Ruk is ubiquitinated but not degraded by the proteasome. Eur J Biochem. 2002 Jul;269(14):3402-8.
|
REF 33 |
SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex. Cell Biochem Funct. 2011 Oct;29(7):589-96.
|
REF 34 |
CIN85 associates with endosomal membrane and binds phosphatidic acid. Cell Res. 2009 Jun;19(6):733-46.
|
REF 35 |
CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities. Int Immunol. 2003 Mar;15(3):313-29.
|
REF 36 |
Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun. 2000 Feb 16;268(2):321-8.
|
REF 37 |
CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies. Mol Biol Cell. 2012 Sep;23(18):3602-11.
|
REF 38 |
Requirement of multiple SH3 domains of Nck for ligand binding. Cell Signal. 1999 Apr;11(4):253-62.
|
REF 39 |
Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45. Blood Cells Mol Dis. 2006 Mar-Apr;36(2):308-14.
|
REF 40 |
Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics. Nat Commun. 2013;4:2863.
|
REF 41 |
Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex. Nat Immunol. 2006 Jan;7(1):57-66.
|
REF 42 |
c-Cbl-facilitated cytoskeletal effects in v-Abl-transformed fibroblasts are regulated by membrane association of c-Cbl. Oncogene. 2007 Jun 14;26(28):4095-105.
|
REF 43 |
SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9775-80.
|
REF 44 |
Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci. 2004 May 15;117(Pt 12):2557-68.
|
REF 45 |
Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem J. 2003 Feb 15;370(Pt 1):29-34.
|
REF 46 |
APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. Oncogene. 1999 Jan 21;18(3):759-67.
|
REF 47 |
Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J Biol Chem. 2005 May 13;280(19):18943-9.
|
REF 48 |
Cloning and characterization of human Src-like adaptor protein 2 and a novel splice isoform, SLAP-2-v. Oncogene. 2003 Jan 16;22(2):266-73.
|
REF 49 |
A novel Src homology 2 domain-containing molecule, Src-like adapter protein-2 (SLAP-2), which negatively regulates T cell receptor signaling. J Biol Chem. 2002 May 24;277(21):19131-8.
|
REF 50 |
A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5413-8.
|
REF 51 |
A dynamic constitutive and inducible binding of c-Cbl by PLCgamma1 SH3 and SH2 domains (negatively) regulates antigen receptor-induced PLCgamma1 activation in lymphocytes. Exp Cell Res. 2003 Sep 10;289(1):184-94.
|
REF 52 |
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46.
|
REF 53 |
EGF-dependent association of phospholipase C-gamma1 with c-Cbl. Exp Cell Res. 2002 Jul 1;277(1):86-94.
|
REF 54 |
Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. EMBO J. 2006 Feb 22;25(4):774-84.
|
REF 55 |
The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun. 2003 Jan 10;300(2):494-500.
|
REF 56 |
SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor. J Biol Chem. 2009 Dec 25;284(52):36062-76.
|
REF 57 |
c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells. Cancer Res. 2008 Nov 1;68(21):8761-9.
|
REF 58 |
c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest. J Biol Chem. 2009 Sep 18;284(38):25664-77.
|
REF 59 |
c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway. Blood. 1998 Jan 1;91(1):46-53.
|
REF 60 |
SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood. 2001 Feb 1;97(3):608-15.
|
REF 61 |
Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. Mol Endocrinol. 1997 Aug;11(9):1213-22.
|
REF 62 |
Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J Biol Chem. 1997 Apr 11;272(15):9979-85.
|
REF 63 |
CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit. Eur J Immunol. 1998 Mar;28(3):1005-15.
|
REF 64 |
p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells. Biochem Biophys Res Commun. 1999 Jan 19;254(2):440-5.
|
REF 65 |
Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem. 2002 Jul 12;277(28):24967-75.
|
REF 66 |
Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem. 2001 Feb 16;276(7):4872-8.
|
REF 67 |
Role of Cbl in shear-activation of PI 3-kinase and JNK in endothelial cells. Biochem Biophys Res Commun. 2002 Apr 12;292(4):892-9.
|
REF 68 |
Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk. Biochem J. 2000 Nov 1;351 Pt 3:669-76.
|
REF 69 |
Association of phosphatidylinositol 3-kinase with the proto-oncogene product Cbl upon CD38 ligation by a specific monoclonal antibody in THP-1 cells. FEBS Lett. 1996 Nov 11;397(1):113-6.
|
REF 70 |
RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol Cell. 2001 Feb;7(2):355-65.
|
REF 71 |
Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Hum Mol Genet. 2010 May 1;19(9):1678-89.
|
REF 72 |
c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G. J Biol Chem. 2012 Feb 17;287(8):5327-39.
|
REF 73 |
Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration. J Biol Chem. 2011 Jan 7;286(1):620-33.
|
REF 74 |
Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene. 2003 Nov 20;22(52):8509-18.
|
REF 75 |
Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem. 2004 Jul 2;279(27):28017-27.
|
REF 76 |
Cbl competitively inhibits epidermal growth factor-induced activation of phospholipase C-gamma1. Mol Cells. 2003 Apr 30;15(2):245-55.
|
REF 77 |
Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively. Cell Signal. 2013 Feb;25(2):470-8.
|
REF 78 |
CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation. Cell Death Differ. 2013 Mar;20(3):443-55.
|
REF 79 |
The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor. J Cell Sci. 2013 Mar 15;126(Pt 6):1366-80.
|
REF 80 |
Threshold-controlled ubiquitination of the EGFR directs receptor fate. EMBO J. 2013 Jul 31;32(15):2140-57.
|
REF 81 |
Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol Cell Biol. 1997 Apr;17(4):2217-25.
|
REF 82 |
Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor. J Biol Chem. 2013 Sep 6;288(36):26323-34.
|
REF 83 |
Weak binding to E3 ubiquitin ligase c-Cbl increases EGFRvA protein stability. FEBS Lett. 2016 May;590(9):1345-53.
|
REF 84 |
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017 May 25;8:15129.
|
REF 85 |
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell. 1999 Dec;4(6):1029-40.
|
REF 86 |
Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Nat Struct Mol Biol. 2012 Jan 22;19(2):184-92.
|
REF 87 |
Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene. 2001 Jul 5;20(30):4058-69.
|
REF 88 |
The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6439-44.
|
REF 89 |
Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells. J Biol Chem. 1997 Jun 27;272(26):16170-5.
|
REF 90 |
A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice. PLoS One. 2009 Oct 13;4(10):e7439.
|
REF 91 |
Effects of the tyrosine kinase inhibitor imatinib mesylate on a Bcr-Abl-positive cell line: suppression of autonomous cell growth but no effect on decreased adhesive property and morphological changes. Int J Hematol. 2003 Oct;78(3):233-40.
|
REF 92 |
Bag1 directly routes immature BCR-ABL for proteasomal degradation. Blood. 2010 Nov 4;116(18):3582-92.
|
REF 93 |
Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl. Exp Hematol. 2004 Jan;32(1):113-21.
|
REF 94 |
Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem. 1998 Dec 25;273(52):35273-81.
|
REF 95 |
Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells. Cell Growth Differ. 2001 Apr;12(4):193-200.
|
REF 96 |
Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol. 2004 Dec;114(6):1317-24.
|
REF 97 |
The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 2001 Dec 17;20(24):7085-95.
|
REF 98 |
Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain. J Immunol. 1999 Dec 1;163(11):5827-35.
|
REF 99 |
The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem. 2000 Jan 7;275(1):414-22.
|
REF 100 |
Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J Biol Chem. 2005 Jan 14;280(2):1543-51.
|
REF 101 |
A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J Biol Chem. 1996 Sep 27;271(39):24063-8.
|
REF 102 |
Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem. 2001 Jul 13;276(28):26004-11.
|
REF 103 |
The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol. 2000 May 1;164(9):4616-26.
|
REF 104 |
Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z. J Biol Chem. 1999 Feb 19;274(8):4883-9.
|
REF 105 |
Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature. 1999 Mar 4;398(6722):84-90.
|
REF 106 |
A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Mol Cell. 2017 Oct 19;68(2):456-470.e10.
|
REF 107 |
Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res. 2006 Jan 1;66(1):283-9.
|
REF 108 |
A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem. 2004 Jul 9;279(28):29565-71.
|
REF 109 |
An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding. FEBS Lett. 2011 Jan 21;585(2):281-5.
|
REF 110 |
Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells. J Exp Ther Oncol. 2010;8(4):297-312.
|
REF 111 |
The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol. 2000 Feb;20(3):851-67.
|
REF 112 |
Specific association of tyrosine-phosphorylated c-Cbl with Fyn tyrosine kinase in T cells. J Biol Chem. 1996 Oct 25;271(43):27130-7.
|
REF 113 |
Phosphorylation of c-Cbl protooncogene product following ethanol administration in rat cerebellum: possible involvement of Fyn kinase. Brain Res. 2002 Sep 20;950(1-2):203-9.
|
REF 114 |
Phospho-tyrosine dependent protein-protein interaction network. Mol Syst Biol. 2015 Mar 26;11(3):794.
|
REF 115 |
C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene. 2002 Feb 7;21(7):1079-89.
|
REF 116 |
Association of Cbl with Fms and p85 in response to macrophage colony-stimulating factor. FEBS Lett. 2000 Jan 21;466(1):96-100.
|
REF 117 |
c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. J Biol Chem. 2002 Apr 26;277(17):14635-40.
|
REF 118 |
Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl. FEBS J. 2006 Dec;273(23):5442-56.
|
REF 119 |
Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 1995 Jun 16;270(24):14347-51.
|
REF 120 |
The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro. Eur J Immunol. 1999 Jul;29(7):2269-79.
|
REF 121 |
Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl. J Biomol NMR. 2000 Apr;16(4):303-12.
|
REF 122 |
SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl. Proteins. 1997 Dec;29(4):545-52.
|
REF 123 |
The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med. 1995 Aug 1;182(2):611-5.
|
REF 124 |
Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation. Oncogene. 2002 Mar 7;21(11):1707-16.
|
REF 125 |
The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase. Biochem Biophys Res Commun. 1999 Apr 2;257(1):129-38.
|
REF 126 |
SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal. 2012 Sep 14;10(1):27.
|
REF 127 |
The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. Int Immunol. 2001 Jan;13(1):13-22.
|
REF 128 |
p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function. Blood. 2009 Apr 2;113(14):3198-208.
|
REF 129 |
Loss of PRMT5 Promotes PDGFR Degradation during Oligodendrocyte Differentiation and Myelination. Dev Cell. 2018 Aug 20;46(4):426-440.e5.
|
REF 130 |
Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol Cell Biol. 1997 Aug;17(8):4597-610.
|
REF 131 |
Thrombopoietin induces activation of the phosphatidylinositol-3' kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL. J Cell Physiol. 1997 Apr;171(1):28-33.
|
REF 132 |
Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway. Traffic. 2008 Feb;9(2):251-66.
|
REF 133 |
Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor. FASEB J. 2013 Feb;27(2):632-44.
|
REF 134 |
Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3794-9.
|
REF 135 |
Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem. 1996 Apr 5;271(14):8435-42.
|
REF 136 |
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation. Sci Signal. 2015 Apr 28;8(374):ra40.
|
REF 137 |
Ligand-induced downregulation of TrkA is partly regulated through ubiquitination by Cbl. FEBS Lett. 2011 Jun 23;585(12):1741-7.
|
REF 138 |
PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting. Cancer Res. 2003 May 1;63(9):2234-43.
|
REF 139 |
Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization. J Cell Sci. 2017 Oct 1;130(19):3282-3296.
|
REF 140 |
Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-B Pathway Via Actin and Tyrosine Kinases. Cell Mol Bioeng. 2009 Sep 1;2(3):341-350.
|
REF 141 |
Signal-transducing adaptor protein-2 regulates integrin-mediated T cell adhesion through protein degradation of focal adhesion kinase. J Immunol. 2007 Aug 15;179(4):2397-407.
|
REF 142 |
c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J Immunol. 2002 Oct 1;169(7):3793-800.
|
REF 143 |
Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol. 2001 Jan 8;152(1):181-95.
|
REF 144 |
A c-Cbl yeast two hybrid screen reveals interactions with 14-3-3 isoforms and cytoskeletal components. Biochem Biophys Res Commun. 1997 Nov 7;240(1):46-50.
|
REF 145 |
Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J Biol Chem. 1996 Jun 14;271(24):14591-5.
|
REF 146 |
Engagement of beta2 integrins recruits 14-3-3 proteins to c-Cbl in human neutrophils. Biochem Biophys Res Commun. 2004 May 14;317(4):1000-5.
|
REF 147 |
Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene. 2004 Sep 16;23(42):7104-15.
|
REF 148 |
Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene. 2004 Mar 4;23(9):1645-55.
|
REF 149 |
Internally tagged ubiquitin: a tool to identify linear polyubiquitin-modified proteins by mass spectrometry. Nat Methods. 2017 May;14(5):504-512.
|
REF 150 |
Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol Cell. 2007 Aug 3;27(3):474-85.
|
REF 151 |
Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat Struct Mol Biol. 2013 Aug;20(8):982-986.
|
REF 152 |
TRAF6-mediated degradation of DOK3 is required for production of IL-6 and TNF in TLR9 signaling. Mol Immunol. 2015 Dec;68(2 Pt C):699-705.
|
REF 153 |
Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation. BMC Biol. 2016 Sep 8;14:76.
|
REF 154 |
Small molecules that bind the Mdm2 RING stabilize and activate p53. Carcinogenesis. 2012 Apr;33(4):791-8.
|
REF 155 |
Methods to Investigate EGFR Ubiquitination. Methods Mol Biol. 2017;1652:81-100.
|
REF 156 |
Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis. Blood. 2013 Dec 5;122(24):3964-72.
|
REF 157 |
Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res. 2008 Jul 15;68(14):5669-77.
|
REF 158 |
Regulation of ubiquitin-binding proteins by monoubiquitination. Nat Cell Biol. 2006 Feb;8(2):163-9.
|
REF 159 |
Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem. 2004 Jul 30;279(31):32786-95.
|
REF 160 |
Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J. 2002 Sep 16;21(18):4796-808.
|
REF 161 |
Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem. 1999 Oct 29;274(44):31707-12.
|
REF 162 |
The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor (PDGFR) Internalization and Signaling. J Biol Chem. 2016 May 27;291(22):11608-18.
|
REF 163 |
All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells. Exp Hematol. 2000 Jul;28(7):826-32.
|
REF 164 |
Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity. 2008 Oct 17;29(4):578-88.
|
REF 165 |
Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association. J Biol Chem. 1999 Feb 19;274(8):5153-62.
|
REF 166 |
Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI). J Immunol. 1998 Nov 15;161(10):5555-63.
|
REF 167 |
IFN-gamma activates the C3G/Rap1 signaling pathway. J Immunol. 2000 Feb 15;164(4):1800-6.
|
REF 168 |
Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl. FEBS Lett. 2004 Nov 19;577(3):555-62.
|
REF 169 |
CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling. J Immunol. 1998 May 15;160(10):5018-27.
|
REF 170 |
Evidence for direct interaction between Sprouty and Cbl. J Biol Chem. 2001 Feb 23;276(8):5866-75.
|
REF 171 |
The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination. Exp Cell Res. 2005 Dec 10;311(2):281-93.
|
REF 172 |
hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr Biol. 2003 Feb 18;13(4):308-14.
|
REF 173 |
Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr Biol. 2003 Feb 18;13(4):297-307.
|
REF 174 |
The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6041-6.
|
REF 175 |
The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination. J Biol Chem. 2011 Jul 8;286(27):24443-50.
|
REF 176 |
Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J Biol Chem. 2007 Mar 23;282(12):9117-26.
|
REF 177 |
Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock. Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L455-71.
|
REF 178 |
Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain. PLoS One. 2010 Sep 22;5(9):e12819.
|
REF 179 |
Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation. Blood. 2003 Mar 1;101(5):1744-51.
|
REF 180 |
The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk. Oncogene. 2000 Aug 17;19(35):4058-65.
|
REF 181 |
Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav. Cell Signal. 2006 Aug;18(8):1219-25.
|
REF 182 |
Constitutive association of EGF receptor with the CrkII-23 mutant that inhibits transformation of NRK cells by EGF and TGF-beta. Cell Signal. 1998 Apr;10(4):283-90.
|
REF 183 |
Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation. Oncogene. 1996 Nov 21;13(10):2067-76.
|
REF 184 |
Protein tyrosine phosphatase inhibitors in Fc gamma RI-induced myeloid oxidant signaling. Exp Cell Res. 1997 Dec 15;237(2):288-95.
|
REF 185 |
Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol. 1997 Jul 1;159(1):70-6.
|
REF 186 |
c-Cbl, a ubiquitin E3 ligase that targets active -catenin: a novel layer of Wnt signaling regulation. J Biol Chem. 2013 Aug 9;288(32):23505-17.
|
REF 187 |
The c-Cbl ubiquitin ligase regulates nuclear -catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway. J Biol Chem. 2015 May 15;290(20):12537-46.
|
REF 188 |
The multidomain protooncogenic protein c-Cbl binds to tubulin and stabilizes microtubules. Exp Cell Res. 2005 May 15;306(1):114-27.
|